Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Emergence des Pathologies Virales, UMR_D 190, Aix-Marseille Université and Institut de Recherche pour le Développement, Marseille, France.
Vaccine. 2015 Dec 8;33(49):7015-21. doi: 10.1016/j.vaccine.2015.09.016. Epub 2015 Sep 19.
Haemagglutination-inhibition (HI) antibody titer is a correlate of protection against influenza; its persistence after infection or vaccination is important to determining susceptibility to subsequent infection. Few studies, however, have reported longitudinal data regarding the magnitude and duration of HI protection following natural seasonal influenza A infection.
Using French influenza cohort study data collected from 2008 to 2010, we investigated persistence of serological protection among subjects according to influenza-like illness (ILI) and laboratory-confirmed seasonal 2007 influenza A(H1N1) infection status at inclusion in 2008 (ILI-A(H1N1) positive, ILI-A(H1N1) negative, or no-ILI). Antibody titers against seasonal 2007 A(H1N1) were determined using the HI technique for sera. Regression models for interval-censored data were used to estimate geometric mean titers (GMT) for HI assays. A logistic regression model adjusted for age group (subjects <30, 30-50 and >50 years old) was used to quantify the association between HI titer and protection against infection.
Based on 310 total subjects, influenza A(H1N1) infection was confirmed in 39 of 115 ILI subjects at inclusion. GMT associated with 50% probability of protection among ILI subjects decreased with age group (subjects <30 yo: GMT of 40.8 was associated with 50% [95CI: 29.3%; 70.7%] probability of protection, subjects 30-50 yo: 26.8 [95CI: 34.4%; 65.6%] and subjects >50 yo: 8.9 [95CI: 15.3%; 84.7%]). GMT declined after the first annual study visit among ILI-A(H1N1) positive subjects but remained higher compared to inclusion at the 2010 study visit (41.5 [95CI: 34.8; 49.5], p=0.0157). GMT remained stable among ILI-A(H1N1) negative subjects (p=0.7502), but decreased among no-ILI subjects (p<0.0001).
Our results confirm the positive relationship between HI titer and probability of protection among naturally infected subjects, and provides evidence that protection associated with HI titer varies with age. This longitudinal analysis suggests the rise in HI titers following seasonal 2007 influenza A(H1N1) infection may persist into subsequent influenza seasons.
血凝抑制(HI)抗体滴度是对流感保护的相关指标;其在感染或接种疫苗后的持久性对于确定对随后感染的易感性很重要。然而,很少有研究报告关于自然季节性流感 A 感染后 HI 保护的幅度和持续时间的纵向数据。
利用 2008 年至 2010 年期间法国流感队列研究的数据,我们根据流感样疾病(ILI)和 2007 年季节性 A(H1N1)流感实验室确诊感染状态(ILI-A(H1N1)阳性、ILI-A(H1N1)阴性或无 ILI),调查了纳入时(ILI-A(H1N1)阳性、ILI-A(H1N1)阴性或无 ILI)受试者中血清学保护的持久性。使用血凝抑制技术测定针对季节性 2007 A(H1N1)的抗体滴度。使用间隔censored 数据的回归模型估计 HI 测定的几何平均滴度(GMT)。使用调整年龄组(<30 岁、30-50 岁和>50 岁)的逻辑回归模型来量化 HI 滴度与感染保护之间的关联。
基于 310 名总受试者,在纳入的 115 名 ILI 受试者中,有 39 名确诊为甲型流感 A(H1N1)感染。ILI 受试者中与 50%保护概率相关的 GMT 随着年龄组而降低(<30 岁组:GMT 为 40.8,与 50%[95CI:29.3%;70.7%]的保护概率相关,30-50 岁组:26.8[95CI:34.4%;65.6%]和>50 岁组:8.9[95CI:15.3%;84.7%])。在 ILI-A(H1N1)阳性受试者的首次年度研究访问后,GMT 下降,但在 2010 年研究访问时仍高于纳入时(41.5[95CI:34.8%;49.5%],p=0.0157)。在 ILI-A(H1N1)阴性受试者中,GMT 保持稳定(p=0.7502),但在无 ILI 受试者中下降(p<0.0001)。
我们的结果证实了 HI 滴度与自然感染受试者的保护概率之间的正相关关系,并提供了证据表明与 HI 滴度相关的保护作用随年龄而变化。这项纵向分析表明,季节性 2007 年甲型流感 A(H1N1)感染后 HI 滴度的升高可能持续到随后的流感季节。